Revive Therapeutics Ltd (RVVTF)

[tcm55]

One of My points was their taking the Time for all date's Interim data reviews of the 210. There are pre 14 day, 28 day, 42 day and 60 day patient reviews. The main Trial is only set for 28 days. The remaining two later review dates per patient must have some meaning. Obviously to see longer term results. 210 interim data is to set dosages for the rest of the Trial and to pass first DSMB reviews. MF said they would also apply for EUA if/when data reviews at 210, 400, 600. Lots of new sites to expedite enrollments. Reliable data collection, DUH...
COVID is slowing (temp?) and Long Haulers are the large future market along with other lung diseases. 'Some' investor(s) have helped recover the PPS. Thiols -Lungs - Buc. JMHFO...GLTA...